Riyadh – Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a leading Saudi pharmaceuticals company, announced today an exclusive license agreement with HK inno.N, a leading Korean pharmaceuticals company, to commercialize Tegoprazan, a novel potassium-competitive acid blocker…
